Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

Friday’s Trading Day
48.90 -0.75 / -1.51%
As of Feb 05
Day’s Change
Monday’s Pre-Market   Switch to standard view »
47.63 -1.27 / -2.60%
Volume: 11.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Operating ActivitiesNet Income / Starting Line1.1B1.5B1.2B1.3B
Total Other Cash Flow-412.9M-530.2M469.4M289.0M
Funds From Operations1.2B1.0B1.8B1.6B
Funds From/For Other Operating Expenses-37.6M425.4M26.7M-167.7M
Net Cash Flow - Operating Activities1.2B609.9M1.8B1.8B
InvestingIncrease In Investments0.000.000.00-300.9M
Decrease In Investments-810.3K49.5M178.6M887.0K
Capital Expenditures-257.9M-113.9M-151.9M-185.8M
Fixed Asset Disposal347.1K342.6M768.9K438.7K
Other Investing - Uses-61.2M0.000.00-29.0M
Other Investing - Sources-10.5M0.000.000.00
Net Cash Flow Investing-277.7M273.6M8.7M-491.2M
FinancingShort Term Borrowings0.
Long Term Borrowings0.
Long Term Debt Reduction0.
Net Proceeds Stock Sale0.
Common Preferred Redeemed-646.3M-564.3M-589.3M-744.4M
Common Dividends----------
Cash Dividends Paid - Total44.0M-1.9B-1.8M-2.5M
Other Sources - Financing0.00347.6M-347.6M0.00
Other Uses - Financing0.
Net Cash Flow - Financing-602.2M-2.1B-938.8M-746.8M
Exchange RateEffect of Exchange Rate on Cash471.6K19.3M-3.1M-6.2M
Net Change In Cash323.7M-1.3B851.0M564.6M